Trending News

Jim Cramer honked his horn and Netflix was kicked to the curb. Such is the power of the stock promoter in the digital age. Cramer, who is credited with coming up with the FAANG acronym that tech investors have used as a roadmap for the past decade, is now pimping MAMAA. It stands for Meta,… [Read More]

By Thomaz Burckhardt On October 29, 2021, 2025  Americans died from COVID-19.  Although the worst times of the pandemic seem to be over, still too many people are dying and many more linger in ICUs on ventilators, on their way to a lonely death by suffocation. Today, the FDA advises there is limited availability of… [Read More]

Generac Holdings Inc (GNRC) is expected to release an earnings report on November 2nd that shows year-over-year earnings of 18.8%. Quarterly earnings on the stock are estimated at $2.47 per share. YTD market performance is at 120.97%, as of Friday, October 29th. Those are big numbers. How are they doing it, and will the uptrend… [Read More]

Hide the beer. Your parents just came home. The crypto space, long viewed by financial professionals as a playground for “amateur” investors, has gone mainstream. On Tuesday, October 19th, 2021, ProShares, an established player in financial services, launched the Bitcoin Strategy ETF (BITO). It’s the first of its kind, and it’s SEC approved. ProShares CEO… [Read More]

Lexaria Bioscience Corp, developers of the revolutionary DehydraTECH™ drug delivery technology, is in the news again this week. On October 13th, the British Columbia-based pharmaceutical company released study results on THC-A21-1, a THC oral format. The study revealed that Lexaria’s DehydraTECH™ THC delivers THC levels to blood-plasma at a rate that is roughly three times… [Read More]

Whistleblowers, despite the negative press they generate, aren’t the biggest problem Facebook is facing right now. Industries rise and fall. That includes social media. It’s unlikely that it will disappear completely, but we are seeing an evolution that could leave Zuckerberg’s empire in ruins. We’re not talking about walls and likes here. The future is… [Read More]

Those of us who grew up in the 60s and 70s have a difficult time wrapping our heads around nuclear energy being a “green” solution for power generation. We remember the fear-based politics of the Cold War, the meltdown at Three Mile Island, and the devastation of Chernobyl. We forget that all happened prior to… [Read More]

Never assume that all the cards are on the table. I made that mistake with Robinhood (HOOD). After months of ranting about overvaluation and the vulnerabilities of PFOF, my objections have been effectively silenced. The announcement this week that Robinhood is adding a crypto wallet has me reevaluating my position. Yes, that’s me saying, “I… [Read More]

HyBryte™ provides a safe treatment alternative for the over 30,000 Americans with cutaneous T cell lymphoma (CTCL) Soligenix is advancing towards NDA filing and U.S. commercialization of HyBryte™ in the treatment of CTCL Company to expand treatment to other cutaneous T cell diseases, including psoriasis, which affects up to 125 million people worldwide Soligenix, a… [Read More]

With great risk comes great reward. Microcap stocks, considered by many to be the most volatile of all securities, are a great example of this. In 2021, ETFs in this sector have outperformed the S&P 500. In most cases, I’m seeing a 2% to 3% difference in year-to-date returns. Compare the two ETFs below as… [Read More]

On this episode, we discover how late stage biopharmaceutical company Soligenix (NASDAQ: SNGX) is developing tools to prepare for the next potential pandemic. [Read More]

Nayib Bukele bought the dip. He tweeted about it. No big deal. Most savvy crypto investors saw the Bitcoin mini crash this week and chose to buy in rather than sell out. Of course, none of those other folks are leaders of a sovereign nation, entrusted with the health of their economy and the welfare… [Read More]